Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
ANVS
#3492
Annovis Bio, Inc.
2.6
9
-2.54%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-2.54%
Variazione Mensile
-9.12%
Variazione di 6 mesi
+14.47%
Variazione Annuale
+46.20%
Chiusura Precedente
2.7
6
Open
2.6
6
Bid
Ask
Low
2.6
6
High
2.6
9
Volume
28
Mercati
Mercato Azionario Statunitense
Salute
ANVS
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
13.8 M
19.49 M
19.49 M
19.49 M
26.5 M
—
Valuation ratios
Enterprise value
98.57 M
87.46 M
6.99 M
25.15 M
39.57 M
159.19 M
Price to earnings ratio
-1.71
-2.18
-0.74
-1.4
-1.74
-6.06
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-3.61
-2.81
-0.89
-1.31
-1.31
-6.32
Price to book ratio
-10.34
6.61
0.59
0.6
0.55
8.36
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.88
-0.42
-0.21
-0.29
-0.42
-1.34
Return on equity %
-1.79
-0.63
-0.23
-0.34
-0.55
-1.75
Return on invested capital %
7 128.56
—
-580.57
519.35
-2 240.34
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.38
2.83
9.03
6.26
4.2
22.32
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.28
-0.68
-0.46
-0.28
-0.18
-1.6
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.1
0.87
1.27
0.93
0.81
3.88
Net current asset value per share
1.12
0.9
1.3
0.95
0.83
3.98
Tangible book value per share
0.62
0.76
1.38
0.99
0.7
3.83
Working capital per share
0.65
0.58
1.15
0.8
0.63
3.17
Book value per share
0.62
0.76
1.38
0.99
0.7
3.83
Notizie
Annovis Bio avvierà studio a lungo termine sul farmaco per il Parkinson a gennaio
Annovis Bio to launch long-term Parkinson’s drug study in January
Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook
Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops
Il direttore di Annovis Bio Hoffman acquista azioni per 193.794 dollari
Annovis Bio director Hoffman buys $193,794 in shares
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling
Il direttore di Annovis Bio Hoffman acquista azioni ANVS per 69.900 dollari
Annovis Bio director Hoffman buys $69.9k in ANVS stock
Il direttore di Annovis Bio Hoffman acquista azioni per 31.649 dollari
Annovis Bio Stock Jumps On Heels Of New Parkinson's Data - Annovis Bio (NYSE:ANVS)
Il trial di fase 3 di Annovis Bio per l’Alzheimer raggiunge il 25% di completamento